NASDAQ: VCRE
Vicore Pharma Holding Ab Earnings Dates, Reports, Calls

Vicore Pharma Holding Ab earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest VCRE earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$11.6M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VCRE reported annual earnings of -$51.9M, with 239.5% growth.

VCRE earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

VCRE Return on Equity

Insufficient data to display

VCRE Return on Assets

Insufficient data to display

Be the first to know when VCRE announces earnings.

VCRE Return on Capital Employed

Current Company
0%
Current Industry
-9.6%

VCRE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.47M-$69.87MN/A-$3.21
ABVC-$7.88M-$8.63MN/A-$0.39
ACET-$99.45M-$108.83MN/A-$13.87
ABVX-$249.95M-$390.82MN/A-$5.28
VRXA-$80.06M-$82.24MN/A-$5.68

Vicore Pharma Holding Ab Earnings Reports & History FAQ

What were Vicore Pharma Holding Ab's earnings last quarter?

Vicore Pharma Holding Ab (NASDAQ: VCRE) reported Q1 2026 earnings per share (EPS) of -$0.04, up 12.5% year over year. Total VCRE earnings for the quarter were -$11.62 million. In the same quarter last year, Vicore Pharma Holding Ab's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Vicore Pharma Holding Ab stock.

Is Vicore Pharma Holding Ab profitable or losing money?

As of the last Vicore Pharma Holding Ab earnings report, Vicore Pharma Holding Ab is currently losing money. Vicore Pharma Holding Ab's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was VCRE's earnings growth in the past year?

As of Vicore Pharma Holding Ab's earnings date in Q3 2026, Vicore Pharma Holding Ab's earnings has grown year over year. VCRE earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.